THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISEASE COMPRISING FARNESYLACETIC ACID AS ACTIVE INGREDIENT

摘要

PROBLEM TO BE SOLVED: To obtain a new substance capable of promoting formation and secretion of mucin in ocular tissues. SOLUTION: This therapeutic agent for keratoconjunctive diseases comprises farneylacetic acid or its salt as an active ingredient. The therapeutic agent for the keratoconjunctive diseases can be applied to dry eye, keratitis, conjunctivitis, ablasion of anterior epithelium of the cornea, corneal ulcer, or the like.